Earlier, in March 2010, Novalar and Sanofi-Aventis signed a license and distribution agreement for OraVerse. The FDA approved OraVerse is indicated for reversal of the soft-tissue anesthesia and
NicVAX is Nabi’s proprietary investigational vaccine being developed to treat nicotine addiction and prevent smoking relapse. Nabi said that the patient enrollment in a second Phase III trial
Keryx said that currently, Perifosine is in Phase 3 clinical development for refractory advanced colorectal cancer and multiple myeloma, both of these Phase 3 programs being conducted under
FluMist allows the vaccine to enter the nose, where the influenza virus usually enters the body, inducing protective immunity. AstraZeneca said that in clinical studies FluMist was effective
Mr Kesaris is expected to report Chris Haudenschild, chairman and CEO of CliniComp and will oversee CliniComp’s financial, operating, marketing and sales functions. Most recently, Kesaris has worked
NEB said that the new products provide all the necessary enzymes and buffers for fast fragment library preparation. The Master Mix Set further streamlines the workflow, reducing the
The acquisition is expected to expand P2i’s product portfolio beyond its technologies for liquid repellency, adding functional coating technologies with applications including anti-bacterial resistance, liquid attracting (super wettable),
Gilead Sciences’ lawsuit against Lupin is based on an abbreviated new drug application filed by Lupin, seeking approval to manufacture and market a generic version of Ranexa before
Watson’s Sevelamer carbonate for oral suspension product is the generic version of Renvela for oral suspension from Genzyme. Renvela is a phosphate binder indicated for the control of
Dactinomycin has received approval from the FDA earlier this year. It is an equivalent of Lundbeck’s Cosmegen. Each single dose vial contains 0.5mg (500mcg) of dactinomycin and 20mg
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.